Ziying Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ziying Wu has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Chao Zeng
Department of Orthopaedics, Xiangya Hospital, Central South University
8 shared publications - Guanghua Lei
Department of Orthopedics Xiangya Hospital, Central South University Changsha China
8 shared publications - Jie Wei
Department of Orthopedics Xiangya Hospital, Central South University Changsha China
8 shared publications - Yilun Wang
Department of Orthopaedics, Xiangya Hospital, Central South University, ChangSha, Hunan, China
8 shared publications - Yuqing Zhang
Massachusetts General Hospital and Harvard Medical School Boston
7 shared publications - Hongyi He
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China
5 shared publications
Latest Publications
- Open Access
- 23 February 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2628363
Response to letter regarding ‘Bidirectional association of daily steps with sarcopenia: a longitudinal study’
To the EditorWe thank Dr Yu and Cui for their interest in our article, ‘Bidirectional association of daily steps with sarcopenia: a longitudinal study,’ [1] and for raising important points regardi...
- 23 February 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2628363
Open AccessResponse to letter regarding ‘Bidirectional association of daily steps with sarcopenia: a longitudinal study’
To the EditorWe thank Dr Yu and Cui for their interest in our article, ‘Bidirectional association of daily steps with sarcopenia: a longitudinal study,’ [1] and for raising important points regardi...
- Open Access
- 19 January 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2614224
Response to letter regarding ‘bidirectional association of daily steps with sarcopenia: a longitudinal study’
- 19 January 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2614224
Open AccessResponse to letter regarding ‘bidirectional association of daily steps with sarcopenia: a longitudinal study’
- 26 December 2025
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (2)
Genetic susceptibility, walking activity and the risk of incident gout
Objectives: Genetic predisposition increases the risk of gout, while walking activity may reduce it. We evaluated whether genetic predisposition modifies the association between walking activity and gout risk. Methods: We included gout-free participants aged 40–70 years from the UK Biobank. Polygenic risk scores (PRS) were calculated using gout-associated single nucleotide polymorphisms, and participants were stratified into three strata according to PRS tertiles. Walking activity data were obtained from 7-day accelerometer recordings. Hazard ratios (HRs), risk differences (RDs) and 95% CIs for incident gout were estimated for moderate and high walking activity levels compared with the low activity within each PRS stratum. Results: Among 86 930 participants (mean age: 61.9 years; 57.3% women), 672 developed gout over a 7-year follow-up. In the high PRS stratum, participants with moderate and high walking volumes had significantly lower rates of incident gout than those with low walking volumes, with HRs (95% CIs) of 0.68 (0.53, 0.87) and 0.55 (0.40, 0.75), respectively. The corresponding 7-year RDs (95% CIs) were –0.64% (–1.00%, –0.27%) and –0.81% (–1.18%, –0.45%). Similar inverse associations were observed in the moderate and low PRS strata. Additionally, higher walking intensity was associated with reduced gout risk across all PRS strata, with the protective effect being more pronounced in the high PRS stratum (P for additive interaction = 0.05). Conclusion: Higher walking activity was associated with a lower risk of gout across all levels of genetic predisposition, with the strongest effects observed in individuals with high genetic susceptibility.
- 26 December 2025
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (2)
Genetic susceptibility, walking activity and the risk of incident gout
Objectives: Genetic predisposition increases the risk of gout, while walking activity may reduce it. We evaluated whether genetic predisposition modifies the association between walking activity and gout risk. Methods: We included gout-free participants aged 40–70 years from the UK Biobank. Polygenic risk scores (PRS) were calculated using gout-associated single nucleotide polymorphisms, and participants were stratified into three strata according to PRS tertiles. Walking activity data were obtained from 7-day accelerometer recordings. Hazard ratios (HRs), risk differences (RDs) and 95% CIs for incident gout were estimated for moderate and high walking activity levels compared with the low activity within each PRS stratum. Results: Among 86 930 participants (mean age: 61.9 years; 57.3% women), 672 developed gout over a 7-year follow-up. In the high PRS stratum, participants with moderate and high walking volumes had significantly lower rates of incident gout than those with low walking volumes, with HRs (95% CIs) of 0.68 (0.53, 0.87) and 0.55 (0.40, 0.75), respectively. The corresponding 7-year RDs (95% CIs) were –0.64% (–1.00%, –0.27%) and –0.81% (–1.18%, –0.45%). Similar inverse associations were observed in the moderate and low PRS strata. Additionally, higher walking intensity was associated with reduced gout risk across all PRS strata, with the protective effect being more pronounced in the high PRS stratum (P for additive interaction = 0.05). Conclusion: Higher walking activity was associated with a lower risk of gout across all levels of genetic predisposition, with the strongest effects observed in individuals with high genetic susceptibility.
- Open Access
- 26 July 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2537353
Bidirectional association of daily steps with sarcopenia: a longitudinal study
Step count is a well-established measure of physical activity, and step-based recommendations offering practical public guidance. However, the bidirectional associations between step count and sarcopenia remain unclear, limiting the application of step-based interventions for sarcopenia prevention. This study examined the directional association between daily steps and sarcopenia. Data were collected from the Xiangya Step Study (a population-based longitudinal study) between January 2020 and December 2022. Average daily steps were tracked via smartphones linked to WeChat, a social networking platform. Sarcopenia was diagnosed using the Asian Workgroup of Sarcopenia 2019 criteria. A two-wave cross-lagged panel model was used to evaluate bidirectional associations between daily steps and sarcopenia. Additionally, logistic regression examines the association between daily steps and incident sarcopenia risk in participants without sarcopenia at baseline. The area under the curve (AUC) was calculated to evaluate the predictive performance of baseline daily steps for incident sarcopenia. The study included 1,281 participants (30.1% women), averaging 52.1 years. A significant bidirectional association was observed: fewer daily steps at baseline were associated with sarcopenia status one year later (cross-lagged path coefficient [β]=-1.20, 95%CI: -1.90 to -0.50, p = 0.001), and sarcopenia status at baseline was associated with decreased daily steps one year later (β=-0.19, 95%CI: -0.23 to -0.15, p < 0.001). Logistic regression indicated that each standard deviation increase in daily steps was associated with a lower risk of incident sarcopenia (adjusted OR = 0.28, 95%CI: 0.09 to 0.89, p = 0.03). The AUC for daily steps was 0.74 (95%CI: 0.56 to 0.92), with an optimal cutoff of 4,888 steps (sensitivity = 0.62, specificity = 0.85). This study highlights a bidirectional inverse association between average daily steps and sarcopenia. Increasing daily steps, especially to 5,000, might help mitigate sarcopenia development. Future research could explore interventions that increase daily steps to prevent sarcopenia and investigate whether sarcopenia reversal could improve physical activity levels.
- 26 July 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2537353
Open AccessBidirectional association of daily steps with sarcopenia: a longitudinal study
Step count is a well-established measure of physical activity, and step-based recommendations offering practical public guidance. However, the bidirectional associations between step count and sarcopenia remain unclear, limiting the application of step-based interventions for sarcopenia prevention. This study examined the directional association between daily steps and sarcopenia. Data were collected from the Xiangya Step Study (a population-based longitudinal study) between January 2020 and December 2022. Average daily steps were tracked via smartphones linked to WeChat, a social networking platform. Sarcopenia was diagnosed using the Asian Workgroup of Sarcopenia 2019 criteria. A two-wave cross-lagged panel model was used to evaluate bidirectional associations between daily steps and sarcopenia. Additionally, logistic regression examines the association between daily steps and incident sarcopenia risk in participants without sarcopenia at baseline. The area under the curve (AUC) was calculated to evaluate the predictive performance of baseline daily steps for incident sarcopenia. The study included 1,281 participants (30.1% women), averaging 52.1 years. A significant bidirectional association was observed: fewer daily steps at baseline were associated with sarcopenia status one year later (cross-lagged path coefficient [β]=-1.20, 95%CI: -1.90 to -0.50, p = 0.001), and sarcopenia status at baseline was associated with decreased daily steps one year later (β=-0.19, 95%CI: -0.23 to -0.15, p < 0.001). Logistic regression indicated that each standard deviation increase in daily steps was associated with a lower risk of incident sarcopenia (adjusted OR = 0.28, 95%CI: 0.09 to 0.89, p = 0.03). The AUC for daily steps was 0.74 (95%CI: 0.56 to 0.92), with an optimal cutoff of 4,888 steps (sensitivity = 0.62, specificity = 0.85). This study highlights a bidirectional inverse association between average daily steps and sarcopenia. Increasing daily steps, especially to 5,000, might help mitigate sarcopenia development. Future research could explore interventions that increase daily steps to prevent sarcopenia and investigate whether sarcopenia reversal could improve physical activity levels.
- Open Access
- 30 May 2023
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 9, e40650
The COVID-19 Pandemic and Daily Steps in the General Population: Meta-analysis of Observational Studies
Background: The COVID-19 pandemic has the potential to accelerate another pandemic: physical inactivity. Daily steps, a proxy of physical activity, are closely related to health. Recent studies indicate that over 7000 steps per day is the critical physical activity standard for minimizing the risk of all-cause mortality. Moreover, the risk of cardiovascular events has been found to increase by 8% for every 2000 steps per day decrement. Objective: To quantify the impact of the COVID-19 pandemic on daily steps in the general adult population. Methods: This study follows the guidelines of the MOOSE (Meta-analysis Of Observational Studies in Epidemiology) checklist. PubMed, EMBASE, and Web of Science were searched from inception to February 11, 2023. Eligible studies were observational studies reporting monitor-assessed daily steps before and during the confinement period of the COVID-19 pandemic in the general adult population. Two reviewers performed study selection and data extraction independently. The modified Newcastle-Ottawa Scale was used to assess the study quality. A random effects meta-analysis was conducted. The primary outcome of interest was the number of daily steps before (ie, January 2019 to February 2020) and during (ie, after January 2020) the confinement period of COVID-19. Publication bias was assessed with a funnel plot and further evaluated with the Egger test. Sensitivity analyses were performed by excluding studies with low methodological quality or small sample sizes to test the robustness of the findings. Other outcomes included subgroup analyses by geographic location and gender. Results: A total of 20 studies (19,253 participants) were included. The proportion of studies with subjects with optimal daily steps (ie, ≥7000 steps/day) declined from 70% before the pandemic to 25% during the confinement period. The change in daily steps between the 2 periods ranged from –5771 to –683 across studies, and the pooled mean difference was –2012 (95% CI –2805 to –1218). The asymmetry in the funnel plot and Egger test results did not indicate any significant publication bias. Results remained stable in sensitivity analyses, suggesting that the observed differences were robust. Subgroup analyses revealed that the decline in daily steps clearly varied by region worldwide but that there was no apparent difference between men and women. Conclusions: Our findings indicate that daily steps declined substantially during the confinement period of the COVID-19 pandemic. The pandemic further exacerbated the ever-increasing prevalence of low levels of physical activity, emphasizing the necessity of adopting appropriate measures to reverse this trend. Further research is required to monitor the consequence of long-term physical inactivity. Trial Registration: PROSPERO CRD42021291684; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=291684
- 30 May 2023
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 9, e40650
Open AccessThe COVID-19 Pandemic and Daily Steps in the General Population: Meta-analysis of Observational Studies
Background: The COVID-19 pandemic has the potential to accelerate another pandemic: physical inactivity. Daily steps, a proxy of physical activity, are closely related to health. Recent studies indicate that over 7000 steps per day is the critical physical activity standard for minimizing the risk of all-cause mortality. Moreover, the risk of cardiovascular events has been found to increase by 8% for every 2000 steps per day decrement. Objective: To quantify the impact of the COVID-19 pandemic on daily steps in the general adult population. Methods: This study follows the guidelines of the MOOSE (Meta-analysis Of Observational Studies in Epidemiology) checklist. PubMed, EMBASE, and Web of Science were searched from inception to February 11, 2023. Eligible studies were observational studies reporting monitor-assessed daily steps before and during the confinement period of the COVID-19 pandemic in the general adult population. Two reviewers performed study selection and data extraction independently. The modified Newcastle-Ottawa Scale was used to assess the study quality. A random effects meta-analysis was conducted. The primary outcome of interest was the number of daily steps before (ie, January 2019 to February 2020) and during (ie, after January 2020) the confinement period of COVID-19. Publication bias was assessed with a funnel plot and further evaluated with the Egger test. Sensitivity analyses were performed by excluding studies with low methodological quality or small sample sizes to test the robustness of the findings. Other outcomes included subgroup analyses by geographic location and gender. Results: A total of 20 studies (19,253 participants) were included. The proportion of studies with subjects with optimal daily steps (ie, ≥7000 steps/day) declined from 70% before the pandemic to 25% during the confinement period. The change in daily steps between the 2 periods ranged from –5771 to –683 across studies, and the pooled mean difference was –2012 (95% CI –2805 to –1218). The asymmetry in the funnel plot and Egger test results did not indicate any significant publication bias. Results remained stable in sensitivity analyses, suggesting that the observed differences were robust. Subgroup analyses revealed that the decline in daily steps clearly varied by region worldwide but that there was no apparent difference between men and women. Conclusions: Our findings indicate that daily steps declined substantially during the confinement period of the COVID-19 pandemic. The pandemic further exacerbated the ever-increasing prevalence of low levels of physical activity, emphasizing the necessity of adopting appropriate measures to reverse this trend. Further research is required to monitor the consequence of long-term physical inactivity. Trial Registration: PROSPERO CRD42021291684; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=291684
- Open Access
- 30 June 2022
- Published by JMIR Publications Inc. in JMIR Preprints
The COVID-19 Pandemic and Daily Steps in the General Population: Meta-analysis of Observational Studies (Preprint)
BACKGROUND The COVID-19 pandemic has the potential to accelerate another pandemic: physical inactivity. Daily steps, a proxy of physical activity, are closely related to health. Recent studies indicate that over 7000 steps per day is the critical physical activity standard for minimizing the risk of all-cause mortality. Moreover, the risk of cardiovascular events has been found to increase by 8% for every 2000 steps per day decrement. OBJECTIVE To quantify the impact of the COVID-19 pandemic on daily steps in the general adult population. METHODS This study follows the guidelines of the MOOSE (Meta-analysis Of Observational Studies in Epidemiology) checklist. PubMed, EMBASE, and Web of Science were searched from inception to February 11, 2023. Eligible studies were observational studies reporting monitor-assessed daily steps before and during the confinement period of the COVID-19 pandemic in the general adult population. Two reviewers performed study selection and data extraction independently. The modified Newcastle-Ottawa Scale was used to assess the study quality. A random effects meta-analysis was conducted. The primary outcome of interest was the number of daily steps before (ie, January 2019 to February 2020) and during (ie, after January 2020) the confinement period of COVID-19. Publication bias was assessed with a funnel plot and further evaluated with the Egger test. Sensitivity analyses were performed by excluding studies with low methodological quality or small sample sizes to test the robustness of the findings. Other outcomes included subgroup analyses by geographic location and gender. RESULTS A total of 20 studies (19,253 participants) were included. The proportion of studies with subjects with optimal daily steps (ie, ≥7000 steps/day) declined from 70% before the pandemic to 25% during the confinement period. The change in daily steps between the 2 periods ranged from –5771 to –683 across studies, and the pooled mean difference was –2012 (95% CI –2805 to –1218). The asymmetry in the funnel plot and Egger test results did not indicate any significant publication bias. Results remained stable in sensitivity analyses, suggesting that the observed differences were robust. Subgroup analyses revealed that the decline in daily steps clearly varied by region worldwide but that there was no apparent difference between men and women. CONCLUSIONS Our findings indicate that daily steps declined substantially during the confinement period of the COVID-19 pandemic. The pandemic further exacerbated the ever-increasing prevalence of low levels of physical activity, emphasizing the necessity of adopting appropriate measures to reverse this trend. Further research is required to monitor the consequence of long-term physical inactivity. CLINICALTRIAL PROSPERO CRD42021291684; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=291684
- 30 June 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe COVID-19 Pandemic and Daily Steps in the General Population: Meta-analysis of Observational Studies (Preprint)
BACKGROUND The COVID-19 pandemic has the potential to accelerate another pandemic: physical inactivity. Daily steps, a proxy of physical activity, are closely related to health. Recent studies indicate that over 7000 steps per day is the critical physical activity standard for minimizing the risk of all-cause mortality. Moreover, the risk of cardiovascular events has been found to increase by 8% for every 2000 steps per day decrement. OBJECTIVE To quantify the impact of the COVID-19 pandemic on daily steps in the general adult population. METHODS This study follows the guidelines of the MOOSE (Meta-analysis Of Observational Studies in Epidemiology) checklist. PubMed, EMBASE, and Web of Science were searched from inception to February 11, 2023. Eligible studies were observational studies reporting monitor-assessed daily steps before and during the confinement period of the COVID-19 pandemic in the general adult population. Two reviewers performed study selection and data extraction independently. The modified Newcastle-Ottawa Scale was used to assess the study quality. A random effects meta-analysis was conducted. The primary outcome of interest was the number of daily steps before (ie, January 2019 to February 2020) and during (ie, after January 2020) the confinement period of COVID-19. Publication bias was assessed with a funnel plot and further evaluated with the Egger test. Sensitivity analyses were performed by excluding studies with low methodological quality or small sample sizes to test the robustness of the findings. Other outcomes included subgroup analyses by geographic location and gender. RESULTS A total of 20 studies (19,253 participants) were included. The proportion of studies with subjects with optimal daily steps (ie, ≥7000 steps/day) declined from 70% before the pandemic to 25% during the confinement period. The change in daily steps between the 2 periods ranged from –5771 to –683 across studies, and the pooled mean difference was –2012 (95% CI –2805 to –1218). The asymmetry in the funnel plot and Egger test results did not indicate any significant publication bias. Results remained stable in sensitivity analyses, suggesting that the observed differences were robust. Subgroup analyses revealed that the decline in daily steps clearly varied by region worldwide but that there was no apparent difference between men and women. CONCLUSIONS Our findings indicate that daily steps declined substantially during the confinement period of the COVID-19 pandemic. The pandemic further exacerbated the ever-increasing prevalence of low levels of physical activity, emphasizing the necessity of adopting appropriate measures to reverse this trend. Further research is required to monitor the consequence of long-term physical inactivity. CLINICALTRIAL PROSPERO CRD42021291684; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=291684
- 7 June 2022
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 134 (8) , 784-794
Comparative risk-benefit profiles of weak opioids in the treatment of osteoarthritis: a network meta-analysis of randomized controlled trials
Despite their poor tolerance, weak opioids are still the most commonly-prescribed medicine for osteoarthritis (OA)-related pain. The objective of this network meta-analysis was to comparatively exa...
- 7 June 2022
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 134 (8) , 784-794
Comparative risk-benefit profiles of weak opioids in the treatment of osteoarthritis: a network meta-analysis of randomized controlled trials
Despite their poor tolerance, weak opioids are still the most commonly-prescribed medicine for osteoarthritis (OA)-related pain. The objective of this network meta-analysis was to comparatively exa...
- 5 April 2022
- Published by Wiley in European journal of pain
- Vol. 26 (6) , 1245-1255
Association between tramadol use and risk of pneumonia in the middle‐aged and elderly populations: a propensity‐score matched cohort study
Background: Tramadol is a widely used weak opioid; however, the evidence for its safety profile in respiratory system needs additional information. We aimed to examine whether tramadol use is associated with an increased risk of pneumonia in the general population.Methods: We conducted five propensity‐score (PS) matched cohort studies in The Health Improvement Network database. Participants aged ≥50‐years initiated tramadol were compared with those initiated one of the following analgesics: codeine (n = 144,506), naproxen (n = 113,028), diclofenac (n = 74,297), celecoxib (n = 42,538), or etoricoxib (n = 27,232). The outcome was incident pneumonia.Outcomes: During 6‐month follow‐up, 395 pneumonia (5.6/1000 person‐years) occurred in the tramadol group and 414 pneumonia (5.9/1000 person‐years) occurred in the PS matched codeine group. Compared with codeine group, the risk of pneumonia was lower in the tramadol group (hazard ratio [HR] = 0.63, 95% confidence interval [CI]: 0.49–0.82) during the first 30‐day follow‐up, but comparable between groups over the entire 6‐month follow‐up (HR = 0.95, 95%CI: 0.83–1.09). In addition, the risk of pneumonia was higher in the tramadol group than that in the PS matched naproxen (HR = 1.68, 95%CI: 1.37–2.06), diclofenac (HR = 1.63, 95%CI: 1.31–2.03), celecoxib (HR = 1.64, 95%CI: 1.20–2.24) or etoricoxib (HR = 1.61, 95%CI: 1.04–2.49) group.Conclusions: The present study indicated that tramadol initiators had a lower risk of incident pneumonia than codeine initiators during the short‐time follow‐up, but had a comparable pneumonia risk compared with codeine initiators and had a higher risk of pneumonia compared with NSAIDs initiators over the entire 6‐month follow‐up duration. Confirmation of the present findings and determination of the underlying mechanism will require more studies.Significance: Tramadol might not be a safer alternative analgesic to codeine or NSAIDs. Both of health‐care providers and patients may need to be on alert for its safety profile in respiratory system in future clinical practice.
- 5 April 2022
- Published by Wiley in European journal of pain
- Vol. 26 (6) , 1245-1255
Association between tramadol use and risk of pneumonia in the middle‐aged and elderly populations: a propensity‐score matched cohort study
Background: Tramadol is a widely used weak opioid; however, the evidence for its safety profile in respiratory system needs additional information. We aimed to examine whether tramadol use is associated with an increased risk of pneumonia in the general population.Methods: We conducted five propensity‐score (PS) matched cohort studies in The Health Improvement Network database. Participants aged ≥50‐years initiated tramadol were compared with those initiated one of the following analgesics: codeine (n = 144,506), naproxen (n = 113,028), diclofenac (n = 74,297), celecoxib (n = 42,538), or etoricoxib (n = 27,232). The outcome was incident pneumonia.Outcomes: During 6‐month follow‐up, 395 pneumonia (5.6/1000 person‐years) occurred in the tramadol group and 414 pneumonia (5.9/1000 person‐years) occurred in the PS matched codeine group. Compared with codeine group, the risk of pneumonia was lower in the tramadol group (hazard ratio [HR] = 0.63, 95% confidence interval [CI]: 0.49–0.82) during the first 30‐day follow‐up, but comparable between groups over the entire 6‐month follow‐up (HR = 0.95, 95%CI: 0.83–1.09). In addition, the risk of pneumonia was higher in the tramadol group than that in the PS matched naproxen (HR = 1.68, 95%CI: 1.37–2.06), diclofenac (HR = 1.63, 95%CI: 1.31–2.03), celecoxib (HR = 1.64, 95%CI: 1.20–2.24) or etoricoxib (HR = 1.61, 95%CI: 1.04–2.49) group.Conclusions: The present study indicated that tramadol initiators had a lower risk of incident pneumonia than codeine initiators during the short‐time follow‐up, but had a comparable pneumonia risk compared with codeine initiators and had a higher risk of pneumonia compared with NSAIDs initiators over the entire 6‐month follow‐up duration. Confirmation of the present findings and determination of the underlying mechanism will require more studies.Significance: Tramadol might not be a safer alternative analgesic to codeine or NSAIDs. Both of health‐care providers and patients may need to be on alert for its safety profile in respiratory system in future clinical practice.
- Open Access
- 22 February 2022
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 23 (1) , 1-18
Associations between adipokines gene polymorphisms and knee osteoarthritis: a meta-analysis
Background: Adipokines gene polymorphisms are speculated to be associated with the risk of knee osteoarthritis (OA), but evidence remains conflicting. This study therefore aimed to examine whether associations exist between adipokines gene polymorphisms and knee OA by considering the evidence collected from eligible studies through a meta-analysis. Methods: A systematic search was performed on PubMed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and Wanfang up to March 31, 2020. Meta-analysis was carried out by focusing on the associations between adipokines gene polymorphisms and knee OA with the allele model, dominant model, and recessive model. Results: The present meta-analysis included 5 eligible studies for ADIPOQ rs1501299 with 1,021 cases and 1,097 controls, 3 eligible studies for ADIPOQ rs2241766 with 549 cases and 544 controls, 3 eligible studies for LEPR rs1137101 with 808 cases and 856 controls, 2 eligible studies for VISFATIN rs4730153 with 339 cases and 680 controls and 2 eligible studies for VISFATIN rs16872158 with 339 cases and 680 controls. Significant association was observed between LEPR rs1137101 and knee OA in the overall population (recessive: OR = 0.40, 95% CI 0.21–0.79). Limited data revealed that associations may exist between ADIPOQ rs2241766 and knee OA in Asians (dominant: OR = 1.35, 95% CI 1.03–1.78), between VISFATIN rs4730153 and knee OA in Asians (allele: OR = 0.58, 95% CI 0.41–0.83; dominant: OR = 0.57, 95% CI 0.39–0.83), and between VISFATIN rs16872158 and knee OA in Asians (allele: OR = 1.84, 95% CI 1.26–2.68; dominant: OR = 1.94, 95% CI 1.31–2.89). Conclusions: Adipokines gene polymorphisms may be associated with knee OA. The association was observed in LEPR rs1137101 in the present study. In addition, limited data revealed that associations may also exist in ADIPOQ rs2241766, VISFATIN rs4730153 and VISFATIN rs16872158. Prospero registration: CRD42020187664.
- 22 February 2022
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 23 (1) , 1-18
Open AccessAssociations between adipokines gene polymorphisms and knee osteoarthritis: a meta-analysis
Background: Adipokines gene polymorphisms are speculated to be associated with the risk of knee osteoarthritis (OA), but evidence remains conflicting. This study therefore aimed to examine whether associations exist between adipokines gene polymorphisms and knee OA by considering the evidence collected from eligible studies through a meta-analysis. Methods: A systematic search was performed on PubMed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and Wanfang up to March 31, 2020. Meta-analysis was carried out by focusing on the associations between adipokines gene polymorphisms and knee OA with the allele model, dominant model, and recessive model. Results: The present meta-analysis included 5 eligible studies for ADIPOQ rs1501299 with 1,021 cases and 1,097 controls, 3 eligible studies for ADIPOQ rs2241766 with 549 cases and 544 controls, 3 eligible studies for LEPR rs1137101 with 808 cases and 856 controls, 2 eligible studies for VISFATIN rs4730153 with 339 cases and 680 controls and 2 eligible studies for VISFATIN rs16872158 with 339 cases and 680 controls. Significant association was observed between LEPR rs1137101 and knee OA in the overall population (recessive: OR = 0.40, 95% CI 0.21–0.79). Limited data revealed that associations may exist between ADIPOQ rs2241766 and knee OA in Asians (dominant: OR = 1.35, 95% CI 1.03–1.78), between VISFATIN rs4730153 and knee OA in Asians (allele: OR = 0.58, 95% CI 0.41–0.83; dominant: OR = 0.57, 95% CI 0.39–0.83), and between VISFATIN rs16872158 and knee OA in Asians (allele: OR = 1.84, 95% CI 1.26–2.68; dominant: OR = 1.94, 95% CI 1.31–2.89). Conclusions: Adipokines gene polymorphisms may be associated with knee OA. The association was observed in LEPR rs1137101 in the present study. In addition, limited data revealed that associations may also exist in ADIPOQ rs2241766, VISFATIN rs4730153 and VISFATIN rs16872158. Prospero registration: CRD42020187664.
- Open Access
- 26 October 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (10) , e21632
Physical Distancing Measures and Walking Activity in Middle-aged and Older Residents in Changsha, China, During the COVID-19 Epidemic Period: Longitudinal Observational Study
Background: Physical distancing measures taken to contain COVID-19 transmission may substantially reduce physical activity levels and cause individuals to adopt a more sedentary lifestyle. Objective: The objective of this study is to determine if there was any change in daily steps, an important component of daily physical activity, and examine risk factors for frequent low daily steps during the COVID-19 epidemic. Methods: We used data collected from the Step Study, a population-based longitudinal study of walking activity among residents aged ≥40 years in Changsha, China. Daily steps were collected via a smartphone linked to WeChat, a social networking platform. We plotted mean daily steps and the prevalence of low daily steps (≤1500 steps/day) 30 days before (reference period) and 30 days after (epidemic period) January 21, 2020 (date of the first COVID-19 case diagnosed in Changsha), and compared it with the same corresponding period from 2019. We examined the association of risk factors with the prevalence of frequent low daily steps (≤1500 steps/day for ≥14 days) using logistic regression. Results: Among 3544 participants (mean age 51.6 years; n=1226 females, 34.6%), mean daily steps dropped from 8097 to 5440 and the prevalence of low daily steps increased from 3% (2287/76,136 person-day) to 18.5% (12,951/70,183 person-day) during the reference and epidemic periods, respectively. No such phenomenon was observed during the corresponding period in 2019. Older age (P for interaction=.001) and female sex (P for interaction<.001) were both associated with a higher prevalence of frequent low daily steps and were more pronounced during the epidemic period. More education was associated with a lower prevalence of frequent low daily steps during the reference period but not the epidemic period (P for interaction=.34). Body mass index or comorbidity were not associated with frequent low daily steps during either period. Conclusions: Daily steps of Changsha residents aged ≥40 years dropped significantly during the COVID-19 period, especially among older adults and females. Although successful physical distancing, measured by the rapid downward trend in daily step counts of residents, played a critical role in the containment of the COVID-19 epidemic, our findings of an increase in the prevalence of frequent low daily steps raise concerns about unintended effects on physical activity.
- 26 October 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (10) , e21632
Open AccessPhysical Distancing Measures and Walking Activity in Middle-aged and Older Residents in Changsha, China, During the COVID-19 Epidemic Period: Longitudinal Observational Study
Background: Physical distancing measures taken to contain COVID-19 transmission may substantially reduce physical activity levels and cause individuals to adopt a more sedentary lifestyle. Objective: The objective of this study is to determine if there was any change in daily steps, an important component of daily physical activity, and examine risk factors for frequent low daily steps during the COVID-19 epidemic. Methods: We used data collected from the Step Study, a population-based longitudinal study of walking activity among residents aged ≥40 years in Changsha, China. Daily steps were collected via a smartphone linked to WeChat, a social networking platform. We plotted mean daily steps and the prevalence of low daily steps (≤1500 steps/day) 30 days before (reference period) and 30 days after (epidemic period) January 21, 2020 (date of the first COVID-19 case diagnosed in Changsha), and compared it with the same corresponding period from 2019. We examined the association of risk factors with the prevalence of frequent low daily steps (≤1500 steps/day for ≥14 days) using logistic regression. Results: Among 3544 participants (mean age 51.6 years; n=1226 females, 34.6%), mean daily steps dropped from 8097 to 5440 and the prevalence of low daily steps increased from 3% (2287/76,136 person-day) to 18.5% (12,951/70,183 person-day) during the reference and epidemic periods, respectively. No such phenomenon was observed during the corresponding period in 2019. Older age (P for interaction=.001) and female sex (P for interaction<.001) were both associated with a higher prevalence of frequent low daily steps and were more pronounced during the epidemic period. More education was associated with a lower prevalence of frequent low daily steps during the reference period but not the epidemic period (P for interaction=.34). Body mass index or comorbidity were not associated with frequent low daily steps during either period. Conclusions: Daily steps of Changsha residents aged ≥40 years dropped significantly during the COVID-19 period, especially among older adults and females. Although successful physical distancing, measured by the rapid downward trend in daily step counts of residents, played a critical role in the containment of the COVID-19 epidemic, our findings of an increase in the prevalence of frequent low daily steps raise concerns about unintended effects on physical activity.